|Articles|October 12, 2012
Trading Away the Medicines of Tomorrow
Author(s)Mike Hennessy
Advertisement
One of the major issues being negotiated right now the amount of protection for the intellectual property of pharmaceutical and biotech companies. And failure to protect the intellectual property rights will actually hurt patients more than the companies.
Click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Medical Economics
1
MedPAC to Congress: Here’s how to rework Medicare’s misaligned incentives
2
MedPAC: $1.1 trillion in Medicare payments are generating the wrong incentives
3
When prior authorization sparks ‘outrage and frustration’
4
What you need to know about financing medical practices
5